AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7069205 — intervention group
Group type: EXPERIMENTAL
Intervention: Peak malar temperature
Number of subjects: 162
Study 30790061 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifampicin
Number of subjects: 0
Study 30790061 — intervention group
Group type: EXPERIMENTAL
Intervention: Probe drugs and endogenous substrates
Number of subjects: 0
Study 29606379 — intervention group
Group type: EXPERIMENTAL
Intervention: Panretinal photocoagulation (PRP)
Number of subjects: 0
Study 29606379 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal ranibizumab (IVR)
Number of subjects: 0
Study 29606379 — intervention group
Group type: EXPERIMENTAL
Intervention: Early vitrectomy (PPV)
Number of subjects: 0
Study 26836729 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous dupilumab (600 mg loading dose followed by 300 mg weekly)
Number of subjects: 60
Study 26836729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 26836729 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous dupilumab
Number of subjects: 60
Study 22753280 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 150 mg/day
Number of subjects: 968
Study 22753280 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine XR 300 mg/day
Number of subjects: 968
Study 22753280 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 968
Study 19508542 — intervention group
Group type: EXPERIMENTAL
Intervention: Stapled haemorrhoidopexy (SH)
Number of subjects: 60
Study 19508542 — intervention group
Group type: COMPARATOR
Intervention: Rubber band ligation (RBL)
Number of subjects: 60
Study 18592619 — intervention group
Group type: EXPERIMENTAL
Intervention: Proactive tacrolimus 0.1% ointment applied twice weekly
Number of subjects: 257
Study 18592619 — intervention group
Group type: COMPARATOR
Intervention: Vehicle ointment applied twice weekly
Number of subjects: 257
Study 15714897 — intervention group
Group type: EXPERIMENTAL
Intervention: Children with chromosome 22q11.2 deletion syndrome
Number of subjects: 0
Study 15714897 — intervention group
Group type: COMPARATOR
Intervention: Typically developing controls
Number of subjects: 0
Study 12106617 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate education program consisting of three group sessions delivered by trained educators.
Number of subjects: 131
Study 12106617 — intervention group
Group type: COMPARATOR
Intervention: Control group (6-month waiting list).
Number of subjects: 131
Study 9990217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 4 micrograms.kg‐1
Number of subjects: 70
Study 9990217 — intervention group
Group type: EXPERIMENTAL
Intervention: Fentanyl 2 micrograms.kg‐1
Number of subjects: 70
Study 9990217 — intervention group
Group type: EXPERIMENTAL
Intervention: Pentazocine 0.5 mg.kg‐1
Number of subjects: 70
Study 9990217 — intervention group
Group type: EXPERIMENTAL
Intervention: Buprenorphine 5 micrograms.kg‐1
Number of subjects: 70
Study 9990217 — intervention group
Group type: COMPARATOR
Intervention: Saline (Control)
Number of subjects: 70
Study 7939455 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback treatment
Number of subjects: 20
Study 7939455 — intervention group
Group type: COMPARATOR
Intervention: Control group (no biofeedback)
Number of subjects: 20
Study 2464358 — intervention group
Group type: EXPERIMENTAL
Intervention: CAF (cyclophosphamide, doxorubicin, 5‐fluorouracil)
Number of subjects: 0
Study 2464358 — intervention group
Group type: COMPARATOR
Intervention: CMF (cyclophosphamide, methotrexate, 5‐fluorouracil)
Number of subjects: 0
Study 2464358 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard chemotherapy (not specified)
Number of subjects: 0
Study 29587625 — intervention group
Group type: EXPERIMENTAL
Intervention: Intranasal oxytocin (OT)
Number of subjects: 28
Study 29587625 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLC)
Number of subjects: 28
Study 26670614 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregabalin (75 mg qid to 300 mg bid)
Number of subjects: 45
Study 26670614 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 45
Study 24409833 — intervention group
Group type: EXPERIMENTAL
Intervention: Q-switched Nd:YAG laser
Number of subjects: 15
Study 24409833 — intervention group
Group type: COMPARATOR
Intervention: Er:YAG micropeel
Number of subjects: 15
Study 22489439 — intervention group
Group type: EXPERIMENTAL
Intervention: Organ donation intervention at DMV offices
Number of subjects: 30
Study 22489439 — intervention group
Group type: COMPARATOR
Intervention: Usual care at DMV offices
Number of subjects: 30
Study 20555274 — intervention group
Group type: EXPERIMENTAL
Intervention: Unstable resistance training
Number of subjects: 18
Study 20555274 — intervention group
Group type: COMPARATOR
Intervention: Stable resistance training
Number of subjects: 18
Study 20555274 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall training (both groups)
Number of subjects: 18
Study 20555274 — intervention group
Group type: COMPARATOR
Intervention: Stable isometric chest press
Number of subjects: 18
Study 18295470 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermittent labor epidural analgesia (ILEA)
Number of subjects: 92
Study 18295470 — intervention group
Group type: COMPARATOR
Intervention: Continuous labor epidural analgesia (CLEA)
Number of subjects: 92
Study 16417778 — intervention group
Group type: EXPERIMENTAL
Intervention: YBK Tablets (40 mg, three times per day)
Number of subjects: 105
Study 16417778 — intervention group
Group type: EXPERIMENTAL
Intervention: Leucogen Tablets (20 mg, three times per day)
Number of subjects: 105
Study 16417778 — intervention group
Group type: COMPARATOR
Intervention: Placebo (Vitamin C tablets 100 mg, three times per day)
Number of subjects: 105
Study 12708879 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril 2mg/Indapamide 0.625 mg
Number of subjects: 471
Study 12708879 — intervention group
Group type: COMPARATOR
Intervention: Atenolol 50mg
Number of subjects: 471
Study 10690162 — intervention group
Group type: EXPERIMENTAL
Intervention: Palm oil (PO)
Number of subjects: 0
Study 10690162 — intervention group
Group type: EXPERIMENTAL
Intervention: Lard (LD)
Number of subjects: 0
Study 10690162 — intervention group
Group type: EXPERIMENTAL
Intervention: Puff-pastry margarine (PPM)
Number of subjects: 0
Study 10690162 — intervention group
Group type: COMPARATOR
Intervention: Obese women (control group)
Number of subjects: 0
Study 10690162 — intervention group
Group type: COMPARATOR
Intervention: Normal-weight women (control group)
Number of subjects: 0
Study 8767824 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-dose fluconazole (150 mg)
Number of subjects: 22
Study 8767824 — intervention group
Group type: EXPERIMENTAL
Intervention: 7-day fluconazole treatment (daily 50 mg)
Number of subjects: 22
Study 1616165 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms) with 40 mL of 1% lidocaine
Number of subjects: 33
Study 1616165 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine (200 micrograms) with 40 mL of 1% lidocaine
Number of subjects: 33
Study 1616165 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms)
Number of subjects: 33
Study 1616165 — intervention group
Group type: COMPARATOR
Intervention: Epinephrine (200 micrograms)
Number of subjects: 33
Study 6589042 — intervention group
Group type: EXPERIMENTAL
Intervention: Early intensification therapy with two doses of asparaginase during induction therapy
Number of subjects: 277
Study 6589042 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed intensification therapy with four doses of asparaginase and cytarabine after remission induction
Number of subjects: 277
Study 6589042 — intervention group
Group type: COMPARATOR
Intervention: Late intensification therapy added to maintenance protocol
Number of subjects: 277
Study 31683942 — intervention group
Group type: EXPERIMENTAL
Intervention: Menu with allergens listed
Number of subjects: 600
Study 31683942 — intervention group
Group type: COMPARATOR
Intervention: Menu without allergens listed
Number of subjects: 600
Study 31683942 — intervention group
Group type: EXPERIMENTAL
Intervention: High Food Neophobia (FN)
Number of subjects: 600
Study 31683942 — intervention group
Group type: EXPERIMENTAL
Intervention: High FN respondents
Number of subjects: 600
Study 31683942 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen content and perceived lack of healthiness
Number of subjects: 600
Study 31683942 — intervention group
Group type: EXPERIMENTAL
Intervention: Food neophobia
Number of subjects: 600
Study 29901865 — intervention group
Group type: EXPERIMENTAL
Intervention: Olfactory training with budesonide irrigations
Number of subjects: 138
Study 29901865 — intervention group
Group type: COMPARATOR
Intervention: Olfactory training with saline irrigations
Number of subjects: 138
Study 27423162 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) self-help workbook
Number of subjects: 503
Study 27423162 — intervention group
Group type: COMPARATOR
Intervention: Wait-list condition
Number of subjects: 503
Study 24326811 — intervention group
Group type: EXPERIMENTAL
Intervention: Diode laser treatment (980 nm wavelength) after biomechanical preparation in Group A
Number of subjects: 60
Study 24326811 — intervention group
Group type: COMPARATOR
Intervention: Conventional method using sodium hypochlorite and hydrogen peroxide in Group B
Number of subjects: 60
Study 22333330 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 727
Study 22333330 — intervention group
Group type: EXPERIMENTAL
Intervention: Feedback only (FB)
Number of subjects: 727
Study 22333330 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing with Feedback (MIFB)
Number of subjects: 727
Study 22333330 — intervention group
Group type: COMPARATOR
Intervention: Assessment Only (AO)
Number of subjects: 727
Study 20153900 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 IU of natural-source vitamin E on alternate days
Number of subjects: 39876
Study 20153900 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 39876
Study 17868455 — intervention group
Group type: EXPERIMENTAL
Intervention: OROS-MPH
Number of subjects: 269
Study 17868455 — intervention group
Group type: EXPERIMENTAL
Intervention: IR-MPH (tid)
Number of subjects: 269
Study 17868455 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 269
Study 15605279 — intervention group
Group type: COMPARATOR
Intervention: Blackcurrant anthocyanin (BCA) 17 mg kg(‐1)
Number of subjects: 20
Study 15605279 — intervention group
Group type: COMPARATOR
Intervention: Blackcurrant anthocyanin (BCA) 7.7 mg kg(‐1)
Number of subjects: 20
Study 15605279 — intervention group
Group type: COMPARATOR
Intervention: Placebo (isoenergetic sugar)
Number of subjects: 20
Study 11796166 — intervention group
Group type: EXPERIMENTAL
Intervention: Cranial electrostimulation (CES)
Number of subjects: 18
Study 11796166 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 10219807 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (cisplatin and 5‐fluorouracil) alternated with radiotherapy (60 Gy/30 fractions)
Number of subjects: 115
Study 10219807 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiotherapy treatment
Number of subjects: 115
Study 8587999 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial syndrome (PS) eating disorders
Number of subjects: 138
Study 8587999 — intervention group
Group type: EXPERIMENTAL
Intervention: Full syndrome (FS) eating disorders (anorexia nervosa or bulimia nervosa)
Number of subjects: 138
Study 8587999 — intervention group
Group type: COMPARATOR
Intervention: Normal controls (NC)
Number of subjects: 138
Study 2082424 — intervention group
Group type: EXPERIMENTAL
Intervention: Four posterior composite resins
Number of subjects: 77
Study 2082424 — intervention group
Group type: EXPERIMENTAL
Intervention: Scanning electron microscopic evaluation
Number of subjects: 77
Study 394062 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical timolol
Number of subjects: 0
Study 394062 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral timolol
Number of subjects: 0
Study 394062 — intervention group
Group type: COMPARATOR
Intervention: Topical timolol alone
Number of subjects: 0
Study 31154316 — intervention group
Group type: EXPERIMENTAL
Intervention: LEGO-based therapy with usual care
Number of subjects: 240
Study 31154316 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 240
Study 27114108 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative physical health-related quality of life
Number of subjects: 447
Study 27114108 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative weight loss
Number of subjects: 447
Study 27114108 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative mental health-related quality of life
Number of subjects: 447
Study 27114108 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative health-related quality of life
Number of subjects: 447
Study 27114108 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcopenia
Number of subjects: 447
Study 26007264 — intervention group
Group type: EXPERIMENTAL
Intervention: Isosorbide Mononitrate (IMN) 40 mg tablet vaginally every 6 hours for a maximum of 4 doses
Number of subjects: 200
Study 26007264 — intervention group
Group type: COMPARATOR
Intervention: Misoprostol 50 μg tablet vaginally every 6 hours for a maximum of 4 doses
Number of subjects: 200
Study 24012648 — intervention group
Group type: EXPERIMENTAL
Intervention: Snus (4mg of nicotine)
Number of subjects: 35
Study 24012648 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 35
Study 24012648 — intervention group
Group type: COMPARATOR
Intervention: Placebo snus
Number of subjects: 35
Study 24012648 — intervention group
Group type: COMPARATOR
Intervention: Placebo alcohol
Number of subjects: 35
Study 21443321 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT plus supportive listening (n = 40)
Number of subjects: 83
Study 21443321 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT plus interpersonal and emotional processing therapy (n = 43)
Number of subjects: 83
Study 21443321 — intervention group
Group type: COMPARATOR
Intervention: Both treatments
Number of subjects: 83
Study 19653755 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual reaction times
Number of subjects: 0
Study 19653755 — intervention group
Group type: EXPERIMENTAL
Intervention: Saccadic reaction times
Number of subjects: 0
Study 19653755 — intervention group
Group type: EXPERIMENTAL
Intervention: Event-related potential latencies
Number of subjects: 0
Study 16829487 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced available processing resources at encoding in younger adults (Experiments 1 and 2)
Number of subjects: 0
Study 16829487 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased available processing resources in both age groups (Experiments 2 and 3)
Number of subjects: 0
Study 16829487 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-recall test asking participants to report items thought of but not recalled
Number of subjects: 0
Study 15104642 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute normovolemic hemodilution (ANH)
Number of subjects: 42
Study 15104642 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 42
Study 15104642 — intervention group
Group type: COMPARATOR
Intervention: Another blood conservation method
Number of subjects: 42
Study 11251875 — intervention group
Group type: EXPERIMENTAL
Intervention: Continence Efficacy Intervention Program (CEIP)
Number of subjects: 48
Study 11251875 — intervention group
Group type: COMPARATOR
Intervention: Conventional intervention
Number of subjects: 48
Study 9287253 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation and EMG biofeedback training (N = 30)
Number of subjects: 44
Study 9287253 — intervention group
Group type: COMPARATOR
Intervention: Assessment only control group (N = 14)
Number of subjects: 44
Study 7683553 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly fluorescent reticulocyte (HFR) counts after autologous BMT
Number of subjects: 42
Study 7683553 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly fluorescent reticulocyte (HFR) counts after allogeneic BMT
Number of subjects: 42
Study 7683553 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly fluorescent reticulocyte (HFR) counts
Number of subjects: 42
Study 3333522 — intervention group
Group type: EXPERIMENTAL
Intervention: Reduced alcohol consumption (Group A)
Number of subjects: 49
Study 3333522 — intervention group
Group type: COMPARATOR
Intervention: Usual alcohol consumption (Group B)
Number of subjects: 49
Study 29126601 — intervention group
Group type: EXPERIMENTAL
Intervention: Open reduction and internal fixation (ORIF) with locked plating
Number of subjects: 0
Study 29126601 — intervention group
Group type: COMPARATOR
Intervention: ORIF with cable plating ± cortical strut allograft
Number of subjects: 0
Study 26916794 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin 20 mg daily
Number of subjects: 17082
Study 26916794 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 17082
Study 25816542 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular vitamin A 5,000 IU 3 times/week for four weeks
Number of subjects: 80
Study 25816542 — intervention group
Group type: COMPARATOR
Intervention: Sham procedure
Number of subjects: 80
Study 22218160 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased intake of oily fish (2 portions of salmon per week providing 3.45 g EPA plus DHA) from 20 weeks gestation until delivery
Number of subjects: 123
Study 22218160 — intervention group
Group type: COMPARATOR
Intervention: Habitual diet low in oily fish (control group)
Number of subjects: 123
Study 19949851 — intervention group
Group type: EXPERIMENTAL
Intervention: Biofeedback-assisted behavioral treatment with Internet-based client-therapist contact
Number of subjects: 19
Study 19949851 — intervention group
Group type: COMPARATOR
Intervention: Passive control
Number of subjects: 19
Study 19067501 — intervention group
Group type: EXPERIMENTAL
Intervention: ScriptAssist telehealth nursing program using psychological techniques, average of 3.5 calls over 9 months.
Number of subjects: 51
Study 19067501 — intervention group
Group type: EXPERIMENTAL
Intervention: ScriptAssist telehealth nursing program using psychological techniques.
Number of subjects: 51
Study 16897917 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard Revised Conflict Tactics Scales (CTS2) categories
Number of subjects: 160
Study 16897917 — intervention group
Group type: COMPARATOR
Intervention: Dichotomous (yes/no) response categories
Number of subjects: 160
Study 16897917 — intervention group
Group type: EXPERIMENTAL
Intervention: Computer administrations
Number of subjects: 160
Study 16897917 — intervention group
Group type: COMPARATOR
Intervention: Paper‐and‐pencil administrations
Number of subjects: 160
Study 16897917 — intervention group
Group type: EXPERIMENTAL
Intervention: Sexual coercion rates
Number of subjects: 160
Study 16897917 — intervention group
Group type: EXPERIMENTAL
Intervention: Gender
Number of subjects: 160
Study 12814227 — intervention group
Group type: EXPERIMENTAL
Intervention: System B HeatSource fitted with a medium plugger at a temperature of 225 degrees C for 5 s on buccal and 5 s on lingual (Group 1)
Number of subjects: 20
Study 12814227 — intervention group
Group type: EXPERIMENTAL
Intervention: System B HeatSource fitted with a medium plugger at a temperature of 225 degrees C for 8 s on buccal and 8 s on lingual (Group 2)
Number of subjects: 20
Study 10653831 — intervention group
Group type: EXPERIMENTAL
Intervention: Alcohol
Number of subjects: 14
Study 10653831 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 8842352 — intervention group
Group type: EXPERIMENTAL
Intervention: Apo E4 allele carriers (n = 71)
Number of subjects: 231
Study 8842352 — intervention group
Group type: EXPERIMENTAL
Intervention: Apo E4 allele carriers with ACE D allele (n = 55)
Number of subjects: 231
Study 8842352 — intervention group
Group type: EXPERIMENTAL
Intervention: Apo E4 and ACE D allele carriers
Number of subjects: 231
Study 1635534 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactitol
Number of subjects: 39
Study 1635534 — intervention group
Group type: COMPARATOR
Intervention: Lactulose
Number of subjects: 39
Study 6477792 — intervention group
Group type: EXPERIMENTAL
Intervention: Metoclopramide i.v.
Number of subjects: 120
Study 6477792 — intervention group
Group type: COMPARATOR
Intervention: Narcotics during established labour
Number of subjects: 120
Study 31136218 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity exercise training (speed endurance training, SET; n = 10)
Number of subjects: 20
Study 31136218 — intervention group
Group type: COMPARATOR
Intervention: Usual lifestyle (control group; n = 10)
Number of subjects: 20
Study 28351689 — intervention group
Group type: EXPERIMENTAL
Intervention: Study-specific HIV algorithm using simple/rapid tests (SRTs)
Number of subjects: 61
Study 28351689 — intervention group
Group type: COMPARATOR
Intervention: Gold standard testing algorithm
Number of subjects: 61
Study 28351689 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined antigen/antibody and single antigen tests
Number of subjects: 61
Study 27603149 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral agents along with Korean Red Ginseng powder capsules (1 gram per dose, 3 grams per day)
Number of subjects: 38
Study 27603149 — intervention group
Group type: COMPARATOR
Intervention: Antiviral agents alone
Number of subjects: 38
Study 24811049 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun protection message that primed mortality and UV-filtered photo of their face
Number of subjects: 0
Study 24811049 — intervention group
Group type: EXPERIMENTAL
Intervention: Reminders of mortality with UV photo framed as revealing appearance consequences of tanning
Number of subjects: 0
Study 22017999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention C (personalised goal setting, 'cook and eat', and education)
Number of subjects: 589
Study 22017999 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention C
Number of subjects: 589
Study 22017999 — intervention group
Group type: EXPERIMENTAL
Intervention: Socially deprived participants (n 119)
Number of subjects: 589
Study 22017999 — intervention group
Group type: COMPARATOR
Intervention: Intervention A (education only)
Number of subjects: 589
Study 22017999 — intervention group
Group type: COMPARATOR
Intervention: Intervention B ('cook and eat' sessions only)
Number of subjects: 589
Study 19382496 — intervention group
Group type: EXPERIMENTAL
Intervention: EPs 7630, a herbal drug preparation from the roots of Pelargonium sidoides, 60 drops three times daily for maximum 22 days
Number of subjects: 103
Study 19382496 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 103